Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers

PURPOSE: Epidermal growth factor receptor (EGFR) mutations have been found in the majority of gefitinib-responsive non-small cell lung cancer (NSCLC) patients from retrospective studies. We sought to compile the available phase II and prospective trials of this EGFR tyrosine kinase inhibitor (TKI) t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Costa, Daniel B., Kobayashi, Susumu, Tenen, Daniel G., Huberman, Mark S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2007
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2551312/
https://ncbi.nlm.nih.gov/pubmed/17610986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2007.05.017
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk